You are currently viewing a new version of our website. To view the old version click .

Application of Venom Phospholipase in the Treatment of Diseases

This special issue belongs to the section “Animal Venoms“.

Special Issue Information

Venom phospholipases consist of hydrolase classes that catalyze the hydrolysis of acyl esters and phosphate esters on phospholipids. The phospholipases A2s are among the most studied ones, as they have been known for over a century from research on snake and bee venom, and many mechanistic studies have been carried out on their numerous isoforms. Besides phospholipase A2 of snake and bee venom, many kinds of phospholipases have been identified in venoms. For example, the venoms of Australian elapid snake, cobra, and brown spider contain phospholipase B, C, and D, respectively.  Phospholipase-like proteins with toxic properties, yet which lack a functional catalytic site, are also found in venoms.

Phospholipases, major digestive enzymes present in venoms, play a critical role in many physiological processes including the generation and aggregation of numerous signaling lipids. In addition, they seem to affect various diseases in some manner. This Special Issue aims to provide a comprehensive view on venom phospholipases, including their characterization, function, and mechanism of action in the treatment of various diseases.

Prof. Dr. Hyunsu Bae
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • phospholipase
  • phospholipase A2
  • venom
  • disease
  • therapy
  • drug

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Toxins - ISSN 2072-6651